Celgene (NASDAQ:CELG)

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotech Short Interest Remains Mixed

The short interest data are out for the most recent settlement date, April 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Celgene, Continental Resources, Hess, Renewable Energy, US Bancorp, Zynga and Many More

Stocks were mixed on Friday despite a stronger than expected payrolls report. There are also six different Fed presidents or governors speaking on Friday, including Janet Yellen and Stanley Fischer. ...
Read Full Story »

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest biotechnology and pharmaceutical companies reporting their earnings on Thursday. With ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, April 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, March 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Big Tech and Biotech Trades Highlight Insider Selling: Gap, Adobe, Celgene, Splunk and More

The going is getting tougher for stocks as earnings reports for the first quarter are starting to roll out. Toss in the geopolitical situation getting more dramatic with the United ...
Read Full Story »

Short Interest Pulls Back in Major Biotechs

The short interest data are out for the most recent settlement date, March 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

If any sector is offering value in what really appears to be a very overbought stock market, it is pharmaceutical, including biotechnology. Absolutely battered during the election cycle when rhetoric over ...
Read Full Story »

Major Biotechs See a Retreat in Short Interest

The short interest data are out for the most recent settlement date, February 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Stocks were indicated lower on Thursday ahead of Friday's key payrolls and unemployment report. The European Central Bank maintained rates at 0.00%. Now that the bull market is officially eight years ...
Read Full Story »
Pills and tablets

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

Despite the incredible market rally since the election of Donald Trump, not all sectors have responded with the same gusto. One that has lagged some is biotech, and while the ...
Read Full Story »
biotech word cloud

Short Sellers Hike Their Bets in Major Biotechs

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »
Exit

Is There More Than Meets the Eye on Celgene’s President, COO Retirement?

Celgene Corp. (NASDAQ: CELG) had seen endless growth and a major stock acceleration in prior years. But that was then, and Wall Street only cares about the upside of the ...
Read Full Story »
automatic inspection machine

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Almost every asset class is overbought now, and the few that aren’t — with the exception of one — have good reasons. Utilities and other income proxy stocks that were big in ...
Read Full Story »